← Eichor
Condition: Acute Liver Failure Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Acute Liver Failure

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of
NA · 1 location(s) · Institute for Clinical and Experimental Medicine · NCT07329036
Evaluation of Fibroscan® Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Departmen
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07449377
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
Phase N/A · 2 location(s) · University Medical Center Groningen · NCT07585890
The Effects of Double Plasma Molecular Adsorption System in Acute on Chronic Liver Failure Patients
NA · 1 location(s) · Chulalongkorn University · NCT05030571
Fecal Microbiota Transplantation for Liver Failure
NA · 1 location(s) · Ningbo Medical Center Lihuili Hospital · NCT05170971
Efficacy and Safety of Citrate Anticoagulation in CRRT for Patients With Liver Failure/DysfuncTION, the CAUTION Trial! A
Phase N/A · 1 location(s) · University Hospital, Antwerp · NCT06908746
Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis
Phase N/A · 3 location(s) · Singapore General Hospital · NCT07438288
Comparison of Blood Products Required Using Two Different ROTEM Cut-offs Before Invasive Procedures in Cirrhosis and Acu
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT06831565
Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia
NA · 1 location(s) · General Hospital of Shenyang Military Region · NCT06922669
F573 for Injection for the Treatment of Liver Injury/Failure
Phase 2 · 10 location(s) · Beijing Continent Pharmaceutical Co, Ltd. · NCT05689645
Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults
Phase 1 · 1 location(s) · RenJi Hospital · NCT05727722
Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospect
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06948565
Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients
Phase 2 · 1 location(s) · Shenzhen Third People's Hospital · NCT06916585
The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure
Phase 1/Phase 2 · 1 location(s) · Hexaell Biotech Co., Ltd. · NCT05989958
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liv
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT07275554
Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure
Phase 1/Phase 2 · 1 location(s) · Beijing 302 Hospital · NCT05985863
Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome
Phase N/A · 3 location(s) · University Hospital, Bonn · NCT03584204
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
Phase N/A · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT04310787
COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device
NA · 1 location(s) · University Hospital, Antwerp · NCT06079021
Study About Hepatic Toxins Kinetic and Evaluation of Organ Damage in Acute on Chronic Liver Failure (ACLF) Patients
Phase N/A · 3 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06837766
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
Phase N/A · 9 location(s) · European Foundation for Study of Chronic Liver Failure · NCT06855056
CytOSorb TreatMent Of Critically Ill PatientS Registry
Phase N/A · 28 location(s) · CytoSorbents, Inc · NCT05146336
SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury
Phase N/A · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06173947
Risk Factors Affecting MSC Efficacy in ACLF Patients
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT07198854
To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose
Phase 2 · 1 location(s) · Sinew Pharma Inc. · NCT05557448
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
Phase N/A · 106 location(s) · European Foundation for Study of Chronic Liver Failure · NCT04613921
A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor
Phase 2 · 9 location(s) · European Foundation for Study of Chronic Liver Failure · NCT05895136
Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT03920618
Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF
Phase N/A · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT04597164
Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
Phase N/A · 1 location(s) · University Hospital, Bonn · NCT04578301
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.